CBS CORPORATION Class B Common Stock Underwriting Agreement
EXECUTION COPY
Exhibit 1.1
Exhibit 1.1
CBS CORPORATION
Class B Common Stock
Underwriting Agreement
Underwriting Agreement
October 14, 2009
Citigroup Global Markets Inc.
As Representative of the several
Underwriters listed in Schedule 1 hereto
c/o Citigroup Global Markets Inc.
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
As Representative of the several
Underwriters listed in Schedule 1 hereto
c/o Citigroup Global Markets Inc.
000 Xxxxxxxxx Xxxxxx
Xxx Xxxx, Xxx Xxxx 00000
Ladies and Gentlemen:
National Amusements, Inc., a Maryland corporation (“NAI”), proposes to cause NAIRI, Inc., a
Delaware corporation and a wholly-owned subsidiary of NAI (the “Selling Stockholder”), to sell to
the several Underwriters listed in Schedule 1 hereto (the “Underwriters,” which term shall include
any underwriter substituted hereinafter as provided in Section 10 hereof), for whom you are acting
as representative (the “Representative”), the number of shares (the “ Firm Shares”) of Class B
Common Stock, $0.001 par value (the “Class B Common Stock”) of CBS Corporation, a Delaware
corporation (the “Company”), set forth in Schedule 1 hereto under the caption “Number of Firm
Shares to be Purchased.” NAI also proposes to grant to the Underwriters an option to purchase up to
the number of additional shares of Class B Common Stock set forth on Schedule 1 hereto under the
caption “Maximum Number of Option Shares to be Purchased” to cover over-allotments, if any (the
“Option Shares” and collectively with the Firm Shares, if any, the “Shares”).
1. Representations and Warranties.
(i) Representation and Warranties of the Company. The Company represents and warrants
to the Underwriters, as of the date hereof, as follows:
(a) Registration Statement and the Prospectus. The Company has filed with the
Securities and Exchange Commission (the “Commission”) a registration statement on Form S-3
(No. 333-154962) under the Securities Act of 1933, as amended (the “1933 Act”) (including
any post-effective amendment thereto and the information (if any) deemed to be part of the
registration statement pursuant to Rule 430A, Rule 430B or Rule
430C under the 1933 Act, the “Registration Statement”) in respect of, among other
things, the Class B Common Stock. The Company meets the requirements for use of
Form S-3
under the 1933 Act. The Registration Statement is an “automatic shelf registration
statement”, as defined in Rule 405 of the 1933 Act, that initially became effective not
earlier than three years prior to the date hereof. The prospectus included in the
Registration Statement is hereinafter referred to as the “Base Prospectus.” The Base
Prospectus, as supplemented by the prospectus supplement specifically relating to the Shares
in the form first used to confirm sales of the Shares (or in the form first made available
to the Underwriters by the Company to meet requests of purchasers pursuant to Rule 173 under
the 0000 Xxx) is hereinafter referred to as the “Prospectus,” and the term “Preliminary
Prospectus” means the preliminary form of the Prospectus dated October 14, 2009. For
purposes of this Agreement, “free writing prospectus” has the meaning set forth in Rule 405
under the 1933 Act, and “Time of Sale Prospectus” means the Preliminary Prospectus together
with the information included in Schedule 2 hereto and the free writing prospectuses, if
any, identified in Schedule 3. As used herein, the terms “Registration Statement,” “Base
Prospectus,” “Preliminary Prospectus,” “Time of Sale Prospectus” and “Prospectus” shall
include the documents, if any, incorporated by reference therein. Any reference herein to
the terms “amend,” “amendment” or “supplement” with respect to the Registration Statement,
the Base Prospectus, the Preliminary Prospectus, the Time of Sale Prospectus and the
Prospectus shall be deemed to refer to and include the filing of any document under the
Securities Exchange Act of 1934, as amended (the “1934 Act”), after the date of this
Underwriting Agreement, or the issue date of the Base Prospectus, the Preliminary
Prospectus, the Time of Sale Prospectus or the Prospectus, as the case may be, deemed to be
incorporated therein by reference.
The Registration Statement, as of the most recent effective date, complied, in all
material respects, with the applicable provisions of the 1933 Act and the applicable rules
and regulations of the Commission thereunder. The Registration Statement, as of the most
recent effective date, did not contain an untrue statement of a material fact or omit to
state a material fact required to be stated therein or necessary to make the statements
therein not misleading. The Time of Sale Prospectus, at October 14, 2009, did not, and at
the Closing Time, will not, contain any untrue statement of a material fact or omit to state
a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading. The Prospectus, as of its date,
and at the Closing Time and as of any Settlement Time, will comply, in all material
respects, with the applicable provisions of the 1933 Act and will not contain an untrue
statement of a material fact or omit to state a material fact necessary in order to make the
statements therein, in the light of the circumstances under which they were made, not
misleading; provided, however, that the Company makes no representations or
warranties as to the information contained in or omitted from the Registration Statement,
the Time of Sale Prospectus or the Prospectus or any amendment thereof or supplement thereto
in reliance upon and in conformity with information furnished to the Company in writing by
NAI or the Selling Stockholder or by or on behalf of any Underwriter through the
Representative or NAI specifically for use in the Registration Statement, the Time of Sale
Prospectus or the Prospectus or any amendment thereof or supplement thereto, it being
understood and agreed that the only such information furnished by or on behalf of any
Underwriter consists of the information described as such in Section 6(b) hereof.
2
(b) Issuer Free Writing Prospectus. Other than the Preliminary Prospectus and
the Prospectus, the Company (including its agents and representatives, other than the
Underwriters in their capacity as such) has not made, used, prepared, authorized, approved
or referred to and will not prepare, make, use, authorize, approve or refer to any free
writing prospectus other than the documents listed on Schedule 3 hereto and other written
communications approved in writing in advance by the Representative.
The documents listed on Schedule 3 hereto, if any, do not include any information that
conflicts with the information contained in the Registration Statement, including any
document incorporated therein by reference and any prospectus supplement deemed to be a part
thereof that has not been superseded or modified. The foregoing sentence does not apply to
statements in or omissions from any documents listed on Schedule 3 based upon and in
conformity with written information furnished to the Company by any Underwriter through the
Representative specifically for use therein.
(c) Incorporated Documents. The documents incorporated by reference in the
Registration Statement, the Time of Sale Prospectus and the Prospectus, at the time they
were or hereafter are, until the Closing Time, filed with the Commission, complied and will
comply, as the case may be, in all material respects with the requirements of the 1934 Act
and the rules and regulations of the Commission thereunder (the “1934 Act Regulations”).
(d) Independent Accountants. To the best of the Company’s knowledge, the
accountants who certified the financial statements and any supporting schedules thereto
included in the Registration Statement, the Time of Sale Prospectus and the Prospectus are
independent public accountants as required by the 1933 Act and the applicable rules and
regulations of the Commission thereunder (the “1933 Act Regulations”).
(e) Financial Statements. The financial statements of the Company included in
the Registration Statement, the Time of Sale Prospectus and the Prospectus, together with
the related schedules and notes, as well as those financial statements, schedules and notes
of any other entity included therein, present fairly the financial position of the Company
at the dates indicated, and the statement of operations, stockholders’ equity and cash flows
of the Company for the periods specified. Such financial statements have been prepared in
conformity with generally accepted accounting principles (“GAAP”) applied on a consistent
basis throughout the periods involved, except as otherwise noted therein and subject, in the
case of interim financial statements, to normal year-end audit adjustments. The supporting
schedules, if any, included in the Registration Statement, the Time of Sale Prospectus and
the Prospectus present fairly in accordance with GAAP the information required to be stated
therein.
(f) No Material Adverse Change in Business. Since the date of the most recent
consolidated financial statements included or incorporated by reference in the
3
Registration
Statement, the Time of Sale Prospectus and the Prospectus, except as otherwise stated
therein, there has been no material adverse change in the financial condition, results of
operations or business affairs of the Company and its subsidiaries considered as one
enterprise (a “Material Adverse Effect”).
(g) Good Standing. The Company is validly existing as a corporation in good
standing under the laws of the State of Delaware and has corporate power and authority to
own, lease and operate its properties and to conduct its businesses as described in the Time
of Sale Prospectus and the Prospectus and to enter into and perform its obligations under,
or as contemplated under, this Underwriting Agreement. The Company is duly qualified as a
foreign corporation to transact business and is in good standing in each other jurisdiction
in which such qualification is required, whether by reason of the ownership or leasing of
property or the conduct of business, except where the failures to so qualify or be in good
standing would not in the aggregate result in a Material Adverse Effect.
(h) Good Standing of Designated Subsidiaries. Each “significant subsidiary” of
the Company (as such term is defined in Rule 1-02 of Regulation S-X promulgated under the
1933 Act), if any, is validly existing as a corporation in good standing under the laws of
the jurisdiction of its incorporation, has corporate power and authority to own, lease and
operate its properties and to conduct its business as described in the Time of Sale
Prospectus and the Prospectus and is duly qualified as a foreign corporation to transact
business and is in good standing in each jurisdiction in which such qualification is
required, whether by reason of the ownership or leasing of property or the conduct of
business, except where the failures to so qualify or be in good standing would not in the
aggregate result in a Material Adverse Effect.
(i) Authorization of Agreements. This Underwriting Agreement has been duly
authorized, executed and delivered by the Company.
(j) Authorization of the Shares. The Shares have been duly authorized and are
validly issued, fully paid and non-assessable and are not subject to any pre-emptive or
similar rights granted by the Company.
(k) Capital Stock of the Company. The Company has an authorized capitalization
as set forth in the Registration Statement, the Time of Sale Prospectus and the Prospectus
under the heading “Capitalization;” except as described in or expressly contemplated by the
Time of Sale Prospectus and the Prospectus, there are no outstanding rights (including,
without limitation, pre-emptive rights), warrants or options to acquire from the Company, or
instruments issued by the Company convertible into or exchangeable for, any shares of
capital stock or other equity interest in the Company, or any contract,
commitment, agreement, understanding or arrangement of any kind relating to the
issuance of any capital stock of the Company, any such convertible or exchangeable
securities or any
4
such rights, warrants or options; the capital stock of the Company
conforms in all material respects to the description thereof contained in the Registration
Statement, the Time of Sale Prospectus and the Prospectus.
(l) Absence of Defaults and Conflicts. The sale of the Shares, the compliance
by the Company with all of the provisions of this Underwriting Agreement and the
consummation of the transactions contemplated herein do not and will not, whether with or
without the giving of notice or passage of time or both, conflict with or constitute a
breach of, or default under, any obligation, agreement, covenant or condition contained in
any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or
other agreement or instrument to which the Company or any of its subsidiaries is a party or
by which it or any of them may be bound, or to which any of the assets, properties or
operations of the Company or any of its subsidiaries is subject, nor will such action result
in any violation of the provisions of the charter or by-laws of the Company or any of its
subsidiaries or any law applicable to the Company, statute, rule, regulation, judgment,
order, writ or decree of any government, government instrumentality or court, domestic or
foreign, having jurisdiction over the Company or any of its subsidiaries or any of its
assets, properties or operations, except, in any such case, for such conflicts, breaches or
violations as would not individually or in the aggregate result in a Material Adverse Effect
or have a material adverse effect on the transactions contemplated by this Underwriting
Agreement.
(m) Absence of Proceedings. There is no action, suit, proceeding, inquiry or
investigation before or brought by any court or governmental agency or body, domestic or
foreign, now pending, or to the knowledge of the Company, threatened, against or affecting
the Company or any of its subsidiaries which is required to be disclosed in the Registration
Statement, the Time of Sale Prospectus and the Prospectus (other than as stated therein).
(n) Absence of Further Requirements. No filing with, or authorization,
approval, consent, license, order, registration, qualification or decree of, any court or
governmental authority or agency, domestic or foreign, is necessary or required for the
performance by the Company of the transactions contemplated under this Underwriting
Agreement, except as otherwise set forth herein, and except such as have been already made,
obtained or rendered, as applicable, and as may be required under state securities or Blue
Sky laws in connection with the purchase and distribution of the Shares by the Underwriters
and as may be required under Regulation 13D or Rule 16a of the 1934 Act, and except where
the failure to obtain any such filing, authorization, approval, consent, license, order,
registration, qualification or decree would not individually or in the aggregate result in a
Material Adverse Effect.
(o) Absence of Market Stabilization or Manipulation. The Company has not
taken, directly or indirectly, any action designed to or that would constitute or that might
be reasonably expected to cause or result in, under the 1934 Act or otherwise,
5
stabilization
or manipulation of the price of any security of the Company to facilitate the sale or resale
of the Shares.
(p) Officer’s Certificates. Any certificate signed by any officer of the
Company or any of its subsidiaries delivered to the Representative or to counsel for the
Underwriters shall be deemed a representation and warranty by the Company to each
Underwriter as to matters covered thereby.
(q) Disclosure Controls. The Company maintains effective disclosure controls
and procedures (as defined in Rule 13a-15(e) of the 0000 Xxx) that are designed to ensure
that information required to be disclosed by the Company in reports that it files or submits
under the 1934 Act is recorded, processed, summarized and reported within the time periods
specified in the Commission’s rules and forms, including controls and procedures designed to
ensure that such information is accumulated and communicated to the Company’s management as
appropriate to allow timely decisions regarding required disclosure. The Company has carried
out evaluations of the effectiveness of its disclosure controls and procedures as required
by Rule 13a-15 of the 1934 Act.
(r) Accounting Controls. The Company maintains processes of internal control
over financial reporting (as defined in Rule 13a-15(f) of the 0000 Xxx) designed by, or
under the supervision of, its principal executive and principal financial officers, or
persons performing similar functions, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial statements for external
purposes in accordance with generally accepted accounting principles. Except as disclosed in
the Registration Statement, the Time of Sale Prospectus and the Prospectus, there are no
material weaknesses in the design or operation of internal control over financial reporting
which are reasonably likely to adversely affect the Company’s ability to record, process,
summarize and report financial information.
(s) Xxxxxxxx-Xxxxx Act. There is and has been no failure in any material
respect on the part of the Company or, to the Company’s knowledge, any of the Company’s
directors or officers, in their capacities as such, to comply with any provision of the
Xxxxxxxx-Xxxxx Act of 2002 and the rules and regulations promulgated in connection therewith
(the “Xxxxxxxx-Xxxxx Act”), including Section 402 related to loans and Sections 302 and 906
related to certifications by the Company’s Chief Executive Officer and Chief Financial
Officer.
(t) Status under the 0000 Xxx. The Company is not an “ineligible issuer” and is
a “well-known seasoned issuer”, in each case, as defined under the 1933 Act, at the times
specified in the 1933 Act in connection with the offering of the Shares.
6
(u) Broadcasting Operations. Except as disclosed in the Registration Statement,
the Time of Sale Prospectus and Prospectus or as would not individually or in the aggregate
result in a Material Adverse Effect: the Company and its subsidiaries hold all material
Federal Communications Commission (the “FCC”) permits, licenses, authorizations and
approvals for its broadcast stations (collectively, the “Authorizations”) that are necessary
to conduct their respective businesses in the manner in which they are currently being
conducted; the Authorizations are in full force and effect; the operations of the stations
owned or operated by the Company or any of its subsidiaries (the “Stations”) are in all
material respects in compliance with the Communications Act of 1934, as amended, and the
rules, regulations, written policies and decisions of the FCC thereunder (collectively, the
“Communications Act”); and all reports and documents that are required by the Communications
Act to be filed with respect to the ownership, management or operation of the Stations have
been duly and timely filed.
(ii) Representations and Warranties of NAI. NAI represents and warrants to the
Underwriters, as of the date hereof, as follows:
(a) Ownership of the Shares. The Selling Stockholder is the beneficial owner
of 46,829,414 shares of the Class A Common Stock of the Company, $0.001 par value per share
(the “Class A Common Stock”) and 22,809,527 shares of the Class B Common Stock, and at the
Closing Time and at any Settlement Time will be the beneficial owner of the Shares
(including those Shares that are issuable upon conversion of the Class A Common Stock) to be
sold by it hereunder free and clear of all liens, encumbrances, equities and claims, and has
full power and authority to sell its interest in the Shares, and, assuming that each
Underwriter acquires its interest in the Shares it has purchased from the Selling
Stockholder without notice of any adverse claim (within the meaning of Section 8-105 of the
New York Uniform Commercial Code (“UCC”), each Underwriter that has purchased such Shares
delivered at the Closing Time and at any Settlement Time to The Depository Trust Company or
other securities intermediary by making payment therefor as provided herein, and that has
had such Shares credited to the securities account or accounts of such Underwriter
maintained with The Depository Trust Company or such other securities intermediary, will
have acquired a security entitlement (within the meaning of Section 8-102(a)(17) of the UCC)
to such Shares purchased by such Underwriter, and no action based on an adverse claim
(within the meaning of Section 8-105 of the UCC) may be asserted against such Underwriter
with respect to such Shares.
(b) Authorization of Agreement. This Underwriting Agreement has been duly
authorized, executed and delivered by NAI.
(c) Absence of Market Stabilization or Manipulation. Neither NAI nor the
Selling Stockholder has taken, directly or indirectly, any action designed to or that would
constitute or that might be reasonably expected to cause or result in, under the 1934 Act or
otherwise, stabilization or manipulation of the price of any security of the Company to
facilitate the sale or resale of the Shares.
7
(d) Absence of Defaults and Conflicts. The execution, delivery and performance
of this Agreement by NAI and the sale of the Shares by the Selling Stockholder do not and
will not, whether with or without the giving of notice or passage of time or both, conflict
with or constitute a breach of, or default under, any obligation, agreement, covenant or
condition contained in any contract, indenture, mortgage, deed of trust, loan or credit
agreement, note, lease or other agreement or instrument to which the Selling Stockholder,
NAI or any of their respective subsidiaries is a party or by which the Selling Stockholder,
NAI or any of their respective subsidiaries may be bound, or to which any of the assets,
properties or operations of the Selling Stockholder, NAI or any of their respective
subsidiaries is subject, nor will such action result in any violation of the provisions of
the charter or by-laws of the Selling Stockholder, NAI or any of their respective
subsidiaries or any law, statute, rule, regulation, judgment, order, writ or decree of any
government, government instrumentality or court, domestic or foreign, having jurisdiction
over the Selling Stockholder, NAI or any of their respective subsidiaries or any of their
assets, properties or operations, except, in any such case, for such conflicts, breaches or
violations as would not individually or in the aggregate result in a Material Adverse Effect
or have a material adverse effect on the transactions contemplated by this Underwriting
Agreement.
(e) Absence of Further Requirements. No filing with, or authorization,
approval, consent, license, order, registration, qualification or decree of, any court or
governmental authority or agency, domestic or foreign, is necessary or required for due
authorization, execution and delivery by NAI of this Underwriting Agreement, the sale and
delivery of the Shares by the Selling Stockholder or for the performance by the Selling
Stockholder or NAI, as the case may be, of the transactions contemplated under this
Underwriting Agreement, except as otherwise set forth herein, and except such as have been
already made, obtained or rendered, as applicable, and as may be required under state
securities or Blue Sky laws in connection with the purchase and distribution of the Shares
by the Underwriters.
(f) Registration Statement and the Prospectus. The sale of the Shares by the
Selling Stockholder pursuant hereto is not prompted by any information concerning the
Company or any of its subsidiaries which is not set forth in the Time of Sale Prospectus and
the Prospectus or any amendment or supplement thereto.
The Time of Sale Prospectus and the Prospectus do not contain and, as amended or
supplemented, if applicable, will not contain, at the Closing Time, any untrue statement of
a material fact or omit to state a material fact necessary to make the statements therein,
in the light of the circumstances under which they were made, not misleading, except that
the representations and warranties set forth in this paragraph are limited to statements or
omissions based upon information relating to the Selling Stockholder or NAI furnished to the
Company in writing by NAI or the Selling Stockholder expressly for use in the Time of Sale
Prospectus and the Prospectus or any amendments or supplements thereto.
8
(g) Officer’s Certificates. Any certificate signed by any officer of NAI
delivered to the Representative or to counsel for the Underwriters shall be deemed a
representation and warranty by NAI to each Underwriter as to matters covered thereby.
(h) Wholly-Owned Subsidiary. NAI is the record and beneficial owner of 100% of
the outstanding capital stock of the Selling Stockholder free and clear of all liens,
encumbrances, equities and claims, except to the extent of the pledge of such stock pursuant
to NAI’s existing debt instruments, and has the right and ability to cause the Selling
Stockholder to sell the Shares and to perform all other acts contemplated to be performed by
it hereunder, except to the extent of the pledge of the Shares pursuant to NAI’s existing
debt instruments.
2. Sale and Delivery to Underwriters; Closing.
(a) Shares. (i) Subject to the terms and conditions set forth herein, NAI agrees to
cause the Selling Stockholder to sell to each of the Underwriters, and each of the Underwriters
agrees, severally and not jointly, to purchase from the Selling Stockholder, at a purchase price of
$11.55 per share, the number of Firm Shares set forth in Schedule 1 hereto opposite the name of
such Underwriter plus any number of Firm Shares which such Underwriter may become obligated to
purchase pursuant to the provisions of Section 10 hereof.
(ii) Subject to the terms and conditions set forth herein, NAI hereby grants an option to the
several Underwriters to purchase, severally and not jointly, and to cause the Selling Stockholder
to sell, up to the number of Option Shares set forth in Schedule 1 hereto at the same purchase
price per share as the Underwriters shall pay for the Firm Shares. Said option may be exercised
only to cover over-allotments in the sale of the Firm Shares by the Underwriters. Said option may
be exercised in whole or in part at any time on or before the 30th day after the date of the
Prospectus upon written or telegraphic notice by the Representatives to the Company and the Selling
Stockholder setting forth the number of Option Shares as to which the several Underwriters are
exercising the option and any Settlement Time. The number of Option Shares to be purchased by each
Underwriter shall be the same percentage of the total number of Option Shares to be purchased by
the several Underwriters as such Underwriter is purchasing of the Firm Shares, subject to such
adjustments as you in your absolute discretion shall make to eliminate any fractional shares.
(b) Payment. Payment of the purchase price for, and delivery of, the Firm Shares
shall be made at the offices of Shearman & Sterling LLP, 599 Lexington Avenue, New York, New York,
or at such other place as shall be agreed upon by the Representative and the Company, at 10:00 A.M.
(Eastern time) on October 20, 2009 (unless postponed in accordance with the provisions of Section
10), or such other time not later than ten business days after such date as shall be agreed upon by
the Representative, the Company and NAI (such time and date of payment and delivery being herein
called the “Closing Time”).
9
If the option provided for in Section 2(a)(ii) hereof shall have been exercised on or before
the third Business Day immediately preceding the Closing Time, payment of the purchase price for,
and delivery of, the Option Shares shall be made at the offices of Shearman & Sterling LLP, 599
Lexington Avenue, New York, New York, or at such other place as shall be agreed upon by the
Representative, the Company and NAI, at the Closing Time.
If the option provided for in Section 2(a)(ii) hereof is exercised after the third Business
Day immediately preceding the Closing Time, payment of the purchase price for, and delivery of, the
Option Shares shall be made at the offices of Shearman & Sterling LLP, 599 Lexington Avenue, New
York, New York, or at such other place as shall be agreed upon by the Representative, the Company
and NAI, at 10:00 A.M. (Eastern time) on the date specified by the Representative (which shall be
within three Business Days after exercise of said option).
The time and date of payment of the purchase price for, and delivery of, the Option Shares is
herein called the “Settlement Time.”
Payment shall be made to NAI by wire transfer of immediately available funds to a bank account
designated by NAI (which, for the avoidance of doubt, may be an account of the Selling
Stockholder), against delivery to the Representative for the respective accounts of the
Underwriters of the Shares to be purchased by them. It is understood that each Underwriter has
authorized the Representative, for its account, to accept delivery of, receipt for, and make
payment of the purchase price for, the Shares which it has severally agreed to purchase. The
Representative, individually and not as representative of the Underwriters, may (but shall not be
obligated to) make payment of the purchase price for the Shares to be purchased by any Underwriter
whose funds have not been received by the Closing Time, but such payment shall not relieve such
Underwriter from its obligations hereunder. Delivery of the Shares shall be made through the
facilities of the Depository Trust Company (“DTC”), Clearstream Luxembourg Banking, société
anonyme, or Euroclear Bank S.A./N.V., as operator of the Euroclear System, unless the
Representative shall otherwise instruct.
NAI will pay all applicable state transfer taxes, if any, involved in the transfer to the
several Underwriters of the Shares to be purchased by them from the Selling Stockholder and the
respective Underwriters will pay any additional stock transfer taxes involved in further transfers
of such Shares by them.
(c) Selling Restrictions. Each Underwriter agrees that it will not offer, sell or
deliver any of the Shares, directly or indirectly, or distribute the Time of Sale Prospectus or the
Prospectus or any other offering material relating to the Shares, in or from any jurisdiction
except under circumstances which will not impose any obligations on the Company or the Selling
Stockholder except as set forth in this Underwriting Agreement.
(d) Free Writing Prospectuses. (i) The Company represents and agrees that, without the
prior consent of the Representative, it has not made and will not make any offer relating to the
Shares that would constitute a “free writing prospectus” as defined in Rule 405 under the 1933 Act;
(ii) each Underwriter represents and agrees that, without the prior consent of the
10
Company, it has not made and will not make any offer relating to the Shares that would
constitute a free writing prospectus required to be filed by the Company with the Commission; (iii)
any such free writing prospectus, the use and content of which have been consented to by the
Company and the Representative is listed on Schedule 3 hereto. Notwithstanding anything to the
contrary herein, the Company and NAI consent to the use by any Underwriter of a free writing
prospectus that contains only (A)(i) information describing only the preliminary terms of the
offering and that is included in Schedule 2 hereto, or (B) other information that is not “issuer
information,” as defined in Rule 433 under the 1933 Act.
3. Covenants.
(i) Covenants of the Company. The Company covenants with each Underwriter, as
follows:
(a) Compliance with Securities Regulations and Commission Requests. The
Company, subject to Section 3(i)(b), will comply with the requirements of Rule 430A, 430B or
430C of the 1933 Act Regulations and Rule 462(b) of the 1933 Act Regulations, if and as
applicable, will file any free writing prospectus to the extent required by Rule 433 under
the 1933 Act, and will notify the Representative immediately, and confirm the notice in
writing, of (i) the effectiveness of any post-effective amendment to the Registration
Statement or the filing of any supplement or amendment to the Prospectus, (ii) the receipt
of any comments from the Commission, (iii) any request by the Commission for any amendment
to the Registration Statement or any amendment or supplement to the Prospectus or for
additional information, and (iv) the issuance by the Commission of any stop order suspending
the effectiveness of the Registration Statement or of any order preventing or suspending the
use of the Prospectus, or of the suspension of the qualification of the Shares for offering
or sale in any jurisdiction, or of the initiation or threatening of any proceedings for any
of such purposes. The Company will promptly effect the filings necessary pursuant to Rule
424 and will take such steps as it deems necessary to ascertain promptly whether the
Prospectus transmitted for filing under Rule 424 was received for filing by the Commission
and, in the event that it was not, it will promptly file the Prospectus. The Company will
make every reasonable effort to prevent the issuance of any stop order and, if any stop
order is issued, to obtain the lifting thereof at the earliest possible moment.
(b) Filing of Amendments. Until the Closing Time, the Company will advise the
Representative promptly of its intention to file or prepare any amendment to the
Registration Statement, any amendment, supplement or revision to the Prospectus, or any free
writing prospectus, will furnish the Representative with copies of any such documents or
communications a reasonable amount of time prior to such proposed filing or use, as the case
may be, and will not file or use any such document or communication to which the
Representative or counsel for the Underwriters shall reasonably object on a timely basis,
unless, in the judgment of the Company or its counsel, such amendment or supplement or other
document or communication is necessary to comply with law.
11
(c) Delivery of Registration Statements. The Company has furnished or, if
requested in writing by the Representative, will deliver to the Representative and counsel
for the Underwriters, without charge, signed copies of the Registration Statement as
originally filed and of each amendment thereto (including exhibits filed therewith or
incorporated by reference therein and documents incorporated or deemed to be incorporated by
reference therein) and signed copies of all consents and certificates of experts, and will
also deliver to the Representative, at no expense to the Underwriters or the Company, one
conformed copy of the Registration Statement as originally filed and of each amendment
thereto (without exhibits) for each of the Underwriters.
(d) Delivery of Prospectuses. The Company will furnish to each Underwriter, at
no expense to the Underwriters or the Company, during the period when the Prospectus is
required to be delivered under the 1933 Act or the 1934 Act (or required to be delivered but
for Rule 172 under the 1933 Act), such number of copies of the Prospectus and each free
writing prospectus as such Underwriter may reasonably request.
(e) Continued Compliance with Securities Laws. The Company will comply in all
material respects with the 1933 Act and the 1933 Act Regulations and the 1934 Act and the
1934 Act Regulations so as to permit the completion of the distribution of the Shares as
contemplated in this Underwriting Agreement and in the Registration Statement, the Time of
Sale Prospectus and the Prospectus. If at any time when the Prospectus is required by the
1933 Act or the 1934 Act to be delivered (or required to be delivered but for Rule 172 under
the 0000 Xxx) in connection with sales of the Shares, any event shall occur or condition
shall exist as a result of which it is necessary to amend the Registration Statement in
order that the Registration Statement will not contain an untrue statement of a material
fact or omit to state a material fact required to be stated therein or necessary to make the
statements therein not misleading or to amend or supplement the Preliminary Prospectus, the
Time of Sale Prospectus or the Prospectus in order that the Preliminary Prospectus, the Time
of Sale Prospectus or the Prospectus will not include an untrue statement of a material fact
or omit to state a material fact necessary in order to make the statements therein not
misleading in the light of the circumstances existing at the time it is delivered to a
purchaser, or if it shall be necessary, in the opinion of counsel for the Company, at any
such time to amend the Registration Statement or amend or supplement the Preliminary
Prospectus, the Time of Sale Prospectus or the Prospectus in order to comply with the
requirements of the 1933 Act or the 1933 Act Regulations, the Company will promptly (i)
notify the Representative of such fact and (ii) prepare and file with the Commission,
subject to Section 3(i)(b), such amendment or supplement as may be necessary to correct such
statement or omission or to make the Registration Statement, the Preliminary Prospectus, the
Time of Sale Prospectus or the Prospectus comply with such requirements, and the Company
will furnish to the Underwriters, at no expense to the Underwriters or the Company, such
number of copies of such amendment or supplement as the Underwriters may reasonably request.
12
(f) Blue Sky Qualifications. The Company will use its best efforts, in
cooperation with the Underwriters, to qualify the Shares for offering and sale under the
applicable securities laws of such states and other jurisdictions (domestic or foreign) as
the Representative may designate and to maintain such qualifications in effect for so long
as required for the distribution of the Shares; provided, however, that the
Company shall not be obligated to file any general consent to service of process or to
qualify as a foreign corporation or as a dealer in securities in any jurisdiction in which
it is not so qualified or to subject itself to taxation in respect of doing business in any
jurisdiction in which it is not otherwise so subject.
(g) Listing. The Company shall use its best efforts to have the Shares listed
and admitted and authorized for trading on the New York Stock Exchange.
(h) Lock-up Agreement. The Company will not, during the period commencing on
the date hereof and ending 30 days after the date of the Prospectus, without the prior
written consent of the Representative, offer, sell, contract to sell, announce the intention
to sell, pledge, or otherwise dispose of (or enter into any transaction which is designed
to, or might reasonably be expected to, result in the disposition (whether by actual
disposition or effective economic disposition due to cash settlement or otherwise) by the
Company or any affiliate of the Company (other than the Selling Stockholder or a controlling
person of the Selling Stockholder) or any person in privity with the Company or any
affiliate of the Company (other than the Selling Stockholder or a controlling person of the
Selling Stockholder)), directly or indirectly, including the filing (or participation in the
filing) of a registration statement with the Commission in respect of, or establish or
increase a put equivalent position or liquidate or decrease a call equivalent position
within the meaning of Section 16 of the Exchange Act, any other shares of Class B Common
Stock or any securities convertible into, or exercisable, or exchangeable for, shares of
Class B Common Stock; or publicly announce an intention to effect any such transaction. The
foregoing sentence shall not apply to (i) the Shares to be sold hereunder; (ii) the issuance
by the Company of shares of Class B Common Stock issuable upon the conversion of securities
(including Class A Common Stock, $0.001 par value, of the Company) or the exercise of
warrants outstanding as of the date hereof; (iii) the issuance by the Company of Class B
Common Stock, options or other securities pursuant to any employee stock option plan, stock
ownership plan or dividend reinvestment plan or any other plan of the Company in effect as
of the date hereof; (iv) the filing of a registration statement on Form S-8 with respect to
any employee stock option plan, stock ownership plan, dividend reinvestment plan or any
other plan described in clause (iii) above; and (v) the entering into an acquisition
agreement, or the public announcement of such agreement, that would provide for the issuance
of Class B Common Stock by the Company, provided that any such issuance may not occur during
the 30-day period described in the foregoing sentence.
(i) Earnings Statement. The Company will timely file such reports pursuant to
the 1934 Act as are necessary in order to make generally available to its
13
securityholders an earnings statement for the purposes of, and to provide the benefits
contemplated by, the last paragraph of Section 11(a) of the 1933 Act. The Company may elect
to rely upon Rule 158 under the 1933 Act and may elect to make such earnings statement
available more frequently than once in any period of twelve months.
(j) DTC. The Company will cooperate with the Representative and use its
reasonable best efforts to permit the Shares to be eligible for clearance and settlement
through the facilities of DTC.
(k) Absence of Market Stabilization or Manipulation. The Company will not
take, directly or indirectly, any action designed to or that would constitute or that might
reasonably be expected to cause or result in, under the 1934 Act or otherwise, stabilization
or manipulation of the price of any security of the Company to facilitate the sale or resale
of the Shares.
(l) Reporting Requirements. The Company, during the period when the Prospectus
is required to be delivered under the 1933 Act or the 1934 Act, will file all documents
required to be filed with the Commission pursuant to the 1934 Act within the time periods
required by the 1934 Act and the 1934 Act Regulations.
(m) Record Retention. The Company will, to the extent required under Rule 433
under the 1933 Act, retain copies of each free writing prospectus that it has used and not
filed with the Commission.
(ii) Covenants of NAI. NAI covenants with each Underwriter, as follows:
(a) Lock-up Agreement. Except for the Shares to be sold hereunder, during the
period commencing on the date hereof and ending 90 days after the date of the Prospectus
without the prior written consent of the Representative, NAI will not cause or permit the
Selling Stockholder to offer, sell, contract to sell, announce the intention to sell,
pledge, or otherwise dispose of (or enter into any transaction which is designed to, or
might reasonably be expected to, result in the disposition (whether by actual disposition or
effective economic disposition due to cash settlement or otherwise) by the Selling
Stockholder or any of its affiliates (other than the Company) or any person in privity with
the Selling Stockholder or any of its affiliates (other than the Company)), directly or
indirectly, including the filing (or participation in the filing) of a registration
statement with the Commission in respect of, or establish or increase a put equivalent
position or liquidate or decrease a call equivalent position within the meaning of Section
16 of the 1934 Act, any other shares of Class B Common Stock or any securities convertible
into, or exercisable, or exchangeable for, shares of Class B Common Stock; or publicly
announce an intention to effect any such transaction; provided, however,
that the Selling Stockholder’s shares of Class A Common Stock and Class B Common Stock are
subject
14
to remedies available to its debt holders upon default under and pursuant to the Selling
Stockholder’s debt instruments as of the date hereof.
(b) Absence of Market Stabilization or Manipulation. NAI will not, and NAI will
not permit the Selling Stockholder to, take, directly or indirectly, any action designed to
or that would constitute or that might reasonably be expected to cause or result in, under
the 1934 Act or otherwise, stabilization or manipulation of the price of any security of the
Company to facilitate the sale or resale of the Shares.
(c) Free Writing Prospectus. NAI represents that it has not prepared or had
prepared on its behalf or used or referred to, and agrees that it will not prepare or have
prepared on its behalf or use or refer to, any Free Writing Prospectus, and has not
distributed and will not distribute any written materials in connection with the offer or
sale of the Shares.
(d) Release of Pledges. NAI shall cause the Selling Stockholder to cause the
Shares to be released from any and all pledges and other liens, encumbrances, equities and
claims under NAI’s existing debt instruments in accordance with the respective terms thereof
such that the Shares may be delivered at the Closing Time and at any Settlement Time, as the
case may be, in accordance with the terms hereof.
4. Payment of Expenses. NAI will pay all expenses incident to the performance of its
and the Company’s obligations under this Underwriting Agreement, including (i) the preparation,
printing and filing of the Registration Statement (including financial statements and any schedules
or exhibits and any document incorporated therein by reference) as originally filed and of each
amendment or supplement thereto, (ii) the preparation, printing and delivery to the Underwriters of
this Underwriting Agreement, any agreement among Underwriters and such other documents as may be
required in connection with the offering, purchase, sale or delivery of the Shares, (iii) the
preparation and delivery of the Shares and any certificates for the Shares to the Underwriters,
including any transfer taxes and any stamp or other duties payable upon the sale or delivery of the
Shares to the Underwriters and any charges of DTC in connection therewith, (iv) the reasonable fees
and disbursements of the Company’s counsel, accountants and other agents (including transfer agents
and registrars), (v) the qualification of the Shares under state securities laws in accordance with
the provisions of Section 3(i)(f) hereof, including filing fees and the reasonable fees and
disbursements of counsel for the Underwriters in connection therewith and in connection with the
preparation, printing and delivery of the Blue Sky Survey, and any amendment thereto, (vi) the
printing and delivery to the Underwriters of copies of the Prospectus and any amendments or
supplements thereto, (vii) the listing of the Shares on the New York Stock Exchange, (viii) the
filing fees incident to, and the reasonable documented fees and disbursements of counsel to the
Underwriters in connection with, the review, if any, by the Financial Industry Regulatory Authority
of the terms of the sale of the Shares and (ix) the filing fees payable to the Commission or
reimbursement for the amount deducted from the Company’s prepaid account with the Commission in
connection with the registration therewith of the Shares.
15
5. Conditions of Underwriters’ Obligations. The obligations of the several
Underwriters to purchase and pay for any Shares under this Underwriting Agreement are subject to
the accuracy of the representations and warranties of the Company and NAI contained in Section 1
hereof or in certificates of any officer of the Company or any of its subsidiaries or of NAI
delivered pursuant to the provisions hereof, to the performance by the Company and NAI of their
respective covenants and other obligations hereunder, and to the following further conditions:
(a) Effectiveness of Registration Statement. No stop order suspending the
effectiveness of the Registration Statement shall have been issued under the 1933 Act and no
proceedings for that purpose, pursuant to Rule 401(g)(2) or pursuant to Section 8A under the 1933
Act, shall have been instituted or be pending or threatened by the Commission. A prospectus
containing information relating to the description of the Shares, the specific method of
distribution and similar matters shall have been filed with the Commission in accordance with
Rule 424 under the 1933 Act Regulations.
(b) Opinion of Counsel for Company. At the Closing Time and at any Settlement Time,
the Representative shall have received the favorable opinion, dated as of the date of the Closing
Time and any Settlement Time, respectively, of Cravath, Swaine & Xxxxx LLP, counsel for the
Company, and/or the general counsel of the Company (or, if such general counsel is not available,
an associate or deputy general counsel to the Company that practices in the area of corporate and
securities law), each in form and substance satisfactory to counsel for the Underwriters, together
with signed or reproduced copies of such letter for each of the other Underwriters, with respect to
such matters as the Underwriters may reasonably request.
(c) Opinion of Counsel for NAI and the Selling Stockholder. At the Closing Time and
at any Settlement Time, the Representative shall have received the favorable opinion, dated as of
the date of the Closing Time and any Settlement Time, respectively, of Shearman & Sterling LLP,
counsel for NAI and the Selling Stockholder, in form and substance satisfactory to counsel for the
Underwriters, together with signed or reproduced copies of such letter for each of the other
Underwriters, with respect to such matters as the Underwriters may reasonably request.
(d) Opinion of In-House Counsel for NAI. At the Closing Time and at any Settlement
Time, the Representatives shall have received the favorable opinion, dated as of the date of the
Closing Time and any Settlement Time, respectively, of Xxxxxxxx Xxxxxxxxx, the Vice President and
General Counsel of NAI, in form and substance satisfactory to counsel for the Underwriters,
together with signed or reproduced copies of such letter for each of the other Underwriters, with
respect to such matters as the Underwriters may reasonably request.
(e) Opinion of Counsel for Underwriters. At the Closing Time and at any Settlement
Time, the Representative shall have received the favorable opinion, dated as of the date of the
Closing Time and any Settlement Time, respectively, of Xxxxxx Xxxxxxx & Xxxx LLP, counsel
16
for the Underwriters, together with signed or reproduced copies of such letter for each of the
other Underwriters, with respect to such matters as the Underwriters may reasonably request.
(f) Officers’ Certificate from the Company. At the Closing Time and at any Settlement
Time, the Representative shall have received a certificate of the Executive Vice President, or a
Senior Vice President or a Vice President of the Company and of the chief financial officer or
chief accounting officer of the Company, dated as of the date of the Closing Time and any
Settlement Time, respectively, to the effect that (x) the representations and warranties in
Section 1(i) are true and correct with the same force and effect as though expressly made at and as
of the Closing Time, (y) the Company has complied with all agreements and satisfied all conditions
on its part to be performed or satisfied in this Agreement at or prior to the Closing Time, and
(z) no stop order suspending the effectiveness of the Registration Statement has been issued and no
proceedings for that purpose have been instituted, are pending or, to the best of such officer’s
knowledge, are threatened by the Commission.
(g) Officers’ Certificate from NAI. At the Closing Time and at any Settlement Time,
the Representative shall have received a certificate of the Executive Vice President, or a Senior
Vice President or a Vice President of NAI and of the chief financial officer or chief accounting
officer of NAI, dated as of the date of the Closing Time and any Settlement Time, respectively, to
the effect that (x) the representations and warranties in Section 1(ii) are true and correct with
the same force and effect as though expressly made at and as of the Closing Time and any Settlement
Time, respectively, and (y) NAI has complied with all agreements and satisfied all conditions on
its part to be performed or satisfied in this Agreement at or prior to the Closing Time or any
Settlement Time, respectively.
(h) Accountant’s Comfort Letter. At the time of the execution of this Underwriting
Agreement, the Representative shall have received from PricewaterhouseCoopers LLP a letter dated
such date, in form and substance satisfactory to the Representative, together with signed or
reproduced copies of such letter for each of the other Underwriters, containing statements and
information of the type ordinarily included in accountants’ “comfort letters” to underwriters with
respect to the financial statements and certain financial information contained or incorporated by
reference in the Registration Statement, the Time of Sale Prospectus and the Prospectus.
(i) Bring-down Comfort Letter. At the Closing Time, the Representative shall have
received from PricewaterhouseCoopers LLP a letter, dated as of the date of the Closing Time, to the
effect that they reaffirm the statements made in the letters furnished pursuant to subsection
(e) of this Section 5, except that the specified date referred to shall be a date not more than
three business days prior to the Closing Time.
(j) Ratings. Subsequent to the execution of this Agreement and prior to the Closing
Time and any Settlement Time, there shall not have occurred any downgrading in the rating of any
debt securities of the Company by Standard & Poor’s Ratings Services, a division of The McGraw Hill
Companies, Inc., Xxxxx’x Investors Service, Inc. or Fitch Ratings Ltd. or any
17
public announcement that any such organization has under surveillance or review its rating of
any debt securities of the Company (other than an announcement with positive implications of a
possible upgrading, and no implication of a possible downgrading, of such rating).
(k) Listing. The Shares shall have been approved for listing on the New York Stock
Exchange, subject to official notice of issuance.
(l) Additional Documents. At the Closing Time and at any Settlement Time, counsel for
the Underwriters shall have been furnished with such documents and opinions as they may reasonably
require for the purpose of enabling them to pass upon the sale of the Shares as herein
contemplated, or in order to evidence the accuracy of any of the representations or warranties, or
the fulfillment of any of the conditions, herein contained; and all proceedings taken by the
Company and NAI in connection with sale of the Shares as herein contemplated shall be satisfactory
in form and substance to the Representative and counsel for the Underwriters.
6. Indemnification.
(a) Indemnification of Underwriters. The Company and NAI severally, and not jointly,
agree to indemnify and hold harmless each Underwriter, each director, officer and affiliate of each
Underwriter, and each person, if any, who controls any Underwriter within the meaning of Section 15
of the 1933 Act or Section 20 of the 1934 Act as follows:
(i) against any and all loss, liability, claim and damage whatsoever, as incurred,
arising out of any untrue statement or alleged untrue statement of a material fact contained
in the Registration Statement (or any amendment thereto) or the omission or alleged omission
therefrom of a material fact required to be stated therein or necessary to make the
statements therein not misleading or arising out of any untrue statement or alleged untrue
statement of a material fact included in the Base Prospectus, the Time of Sale Prospectus,
the Prospectus (or any amendment or supplement thereto), any free writing prospectus that
the Company has filed, or is required to file, pursuant to Rule 433(d) under the 1933 Act,
or the omission or alleged omission therefrom of a material fact necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not
misleading;
(ii) against any and all loss, liability, claim and damage whatsoever, as incurred, to
the extent of the aggregate amount paid in settlement of any litigation, or any
investigation or proceeding by any governmental agency or body, commenced or threatened, or
any claim whatsoever based upon any such untrue statement or omission, or any such alleged
untrue statement or omission; provided that any such settlement is effected with the written
consent of the Company; and
(iii) against any and all out of pocket expense as reasonably incurred (including,
subject to the limitations set forth in Section 6(c), the fees and disbursements of counsel
chosen by the Representative), in investigating, preparing or defending against
18
any litigation, or any investigation or proceeding by any governmental agency or body,
commenced or threatened, or any claim whatsoever based upon any such untrue statement or
omission, or any such alleged untrue statement or omission, to the extent that any such
expense is not paid under (i) or (ii) above;
provided, however, that (x) notwithstanding any other provision herein, any loss,
liability, claim, damage or expense shall only give rise under the indemnity agreement contained in
this Section 6 to liability for NAI if such loss, liability, claim, damage or expense arises out of
any untrue statement or omission or alleged untrue statement or omission made in reliance upon and
in conformity with written information furnished to the Company by NAI or the Selling Stockholder
expressly for use in the Registration Statement (or any amendment thereto), the Time of Sale
Prospectus, the Prospectus (or any amendment or supplement thereto), or any free writing prospectus
that the Company has filed, or is required to file, pursuant to Rule 433(d) under the 1933 Act; and
(y) this indemnity agreement shall not give rise to liability for the Company or NAI with respect
to any loss, liability, claim, damage or expense to the extent arising out of any untrue statement
or omission or alleged untrue statement or omission made in reliance upon and in conformity with
written information furnished to the Company by any Underwriter through the Representative
expressly for use in the Registration Statement (or any amendment thereto), the Time of Sale
Prospectus, the Prospectus (or any amendment or supplement thereto), or any free writing prospectus
that the Company has filed, or is required to file, pursuant to Rule 433(d) under the 1933 Act and
(z) this indemnity agreement shall not give rise to liability for the Company with respect to any
loss, liability, claim, damage or expense to the extent arising out of any untrue statement or
omission or alleged untrue statement or omission made in reliance on and in conformity with written
information furnished to the Company by NAI or a controlling person of NAI or the Selling
Stockholder or a controlling person of the Selling Stockholder expressly for use in the
Registration Statement or any amendment thereto) the Time of Sale Prospectus, the Prospectus (or
any amendment or supplement thereto), or any free writing prospectus that the Company has filed, or
is required to file, pursuant to Rule 433(d) under the 1933 Act; provided, further,
however, that, notwithstanding any other provision herein, the liability of NAI under the
indemnity agreement contained in this Section 6 shall be limited to an amount equal to the proceeds
(after deducting Underwriters’ discounts but before expenses) received by the Selling Stockholder
from the sale of the Shares by it under this Agreement.
(b) Indemnification of Company, NAI, Directors and Officers. Each Underwriter
severally agrees to indemnify and hold harmless the Company, its directors, each of its officers
who signed the Registration Statement, NAI, its directors and officers, and each person, if any,
who controls the Company or NAI within the meaning of Section 15 of the 1933 Act or Section 20 of
the 1934 Act against any and all loss, liability, claim, damage and expense described in the
indemnity contained in subsection (a) of this Section, as incurred, but only with respect to untrue
statements or omissions, or alleged untrue statements or omissions, made in the Registration
Statement (or any amendment thereto), the Time of Sale Prospectus, the Prospectus (or any amendment
or supplement thereto), or any free writing prospectus that the Company has filed, or is required
to file, pursuant to Rule 433(d) under the 1933 Act in reliance upon and in conformity with written
information furnished to the Company by such Underwriter through the Representative expressly for
use in the Registration Statement (or any amendment thereto), such
19
Base Prospectus, the Time of Sale Prospectus, the Prospectus (or any amendment or supplement
thereto), or such free writing prospectus that the Company has filed, or is required to file,
pursuant to Rule 433(d) under the 1933 Act. The Company and NAI acknowledge that the statements set
forth in (i) the last paragraph of the cover page regarding delivery of the Shares, (ii) the first
paragraph under the heading “Commissions and Discounts” in the “Underwriting” section, (iii) the
first, second and third paragraphs under the heading “Price Stabilization and Short Positions” in
the “Underwriting” section, (iv) the list of Underwriters and their respective participation in the
sale of the Shares, and (v) the sentences related to concessions and reallowances in any
Preliminary Prospectus and the Prospectus constitute the only information furnished in writing by
or on behalf of the Underwriters for inclusion in any Preliminary Prospectus, Prospectus or any
issuer free writing prospectus. This indemnity agreement will be in addition to any liabilities
which any Underwriter may otherwise have.
(c) Actions Against Parties; Notification. Each indemnified party shall promptly give
written notice to each indemnifying party of any action commenced against it in respect of which
indemnity may be sought hereunder, but failure to so notify an indemnifying party shall not relieve
such indemnifying party from any liability hereunder to the extent it is not materially prejudiced
as a result thereof and in any event shall not relieve it from any liability which it may have
otherwise than on account of this indemnity agreement. The indemnifying party shall be entitled to
appoint counsel of the indemnifying party’s choice at the indemnifying party’s expense to represent
the indemnified party in any action for which indemnification is sought (in which case the
indemnifying party shall not thereafter be responsible for the fees and expenses of any separate
counsel retained by the indemnified party or parties except as set forth below); provided,
however, that such counsel shall be reasonably satisfactory to the indemnified party. Any
indemnified party shall have the right to employ separate counsel in any such action, but the fees
and expenses of such separate counsel shall be at the expense of the indemnified party unless (i)
the employment of such counsel shall have been specifically authorized in writing by the
indemnifying party, (ii) the indemnifying party shall have failed promptly to assume the defense
and employ counsel reasonably satisfactory to the indemnified party or (iii) the named parties to
any such action shall include both indemnified party and the indemnifying party, and such
indemnified party shall have been advised by counsel that there may be one or more legal defenses
available to it which are different from, or additional to, those available to the indemnifying
party, it being understood, however, that the indemnifying party shall not, in connection with any
one such action or separate but substantially similar or related actions in the same jurisdiction
arising out of the same general allegations or circumstances, be liable for the reasonable fees and
expenses of more than one separate firm of attorneys (in addition to any local counsel) for all
such indemnified parties, which firm shall be designated in writing by the Representative on behalf
of all of such indemnified parties. No indemnifying party shall, without the prior written consent
of the indemnified parties, settle or compromise or consent to the entry of any judgment with
respect to any litigation, or any investigation or proceeding by any governmental agency or body,
commenced or threatened, or any claim whatsoever in respect of which indemnification or
contribution could be sought under this Section 6 or Section 7 hereof, unless such settlement,
compromise or consent includes an unconditional release of each indemnified party from all
liability arising out of such litigation, investigation, proceeding or claim.
20
7. Contribution. If the indemnification provided for in Section 6 hereof is for any
reason unavailable to or insufficient to hold harmless an indemnified party in respect of any
losses, liabilities, claims, damages or expenses referred to therein, then each indemnifying party
shall contribute to the aggregate amount of such losses, liabilities, claims, damages and expenses
incurred by such indemnified party, as incurred, (i) in such proportion as is appropriate to
reflect the relative benefits received by the Company and NAI, on the one hand, and the
Underwriters, on the other hand, from the offering of the Shares pursuant to this Underwriting
Agreement or (ii) if the allocation provided by clause (i) is not permitted by applicable law, in
such proportion as is appropriate to reflect not only the relative benefits referred to in clause
(i) above but also the relative fault of the Company and NAI, on the one hand, and of the
Underwriters, on the other hand, in connection with the statements or omissions which resulted in
such losses, liabilities, claims, damages or expenses, as well as any other relevant equitable
considerations.
The relative benefits received by the Company and NAI, on the one hand, and the Underwriters,
on the other hand, in connection with the offering of the Shares under this Underwriting Agreement
shall be deemed to be in the same respective proportions as the total net proceeds from the
offering of such Shares (before deducting expenses) received by the Selling Stockholder bear to the
total underwriting discounts and commissions received by the Underwriters, in each case as set
forth in the table on the cover page of the Prospectus.
The relative fault of the Company and NAI, on the one hand, and the Underwriters, on the other
hand, shall be determined by reference to, among other things, whether any such untrue or alleged
untrue statement of a material fact or omission or alleged omission to state a material fact
relates to information supplied by the Company, NAI or by the Underwriters and the parties’
relative intent, knowledge, access to information and opportunity to correct or prevent such
statement or omission.
The Company, NAI and the Underwriters agree that it would not be just and equitable if
contribution pursuant to this Section 7 were determined by pro rata allocation (even if the
Underwriters were treated as one entity for such purpose) or by any other method of allocation
which does not take account of the equitable considerations referred to above in this Section 7.
Notwithstanding the provisions of this Section 7, (i) NAI shall not be required to contribute
any amount in excess of the amount equal to the proceeds (after deducting Underwriters’ discounts
but before expenses) received by NAI and/or the Selling Stockholder from the sale of the Shares by
it under this Agreement, and (ii) no Underwriter shall be required to contribute any amount in
excess of the amount by which the total price at which the Shares underwritten by it and
distributed to the public were offered to the public exceeds the amount of any damages which such
Underwriter has otherwise been required to pay by reason of any such untrue or alleged untrue
statement or omission or alleged omission.
No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the
0000 Xxx) shall be entitled to contribution from any person who was not guilty of such fraudulent
misrepresentation.
For purposes of this Section 7, each person, if any, who controls an Underwriter within the
meaning of Section 15 of the 1933 Act or Section 20 of the 1934 Act and each director,
21
officer and affiliate of each Underwriter, shall have the same rights to contribution as such
Underwriter, and each director of the Company, each officer of the Company who signed the
Registration Statement, and each person, if any, who controls the Company within the meaning of
Section 15 of the 1933 Act or Section 20 of the 1934 Act shall have the same rights to contribution
as the Company. The Underwriters’ respective obligations to contribute pursuant to this Section 7
are several in proportion to the aggregate principal amount of Shares set forth opposite their
respective names in Schedule 1 hereto, and not joint.
8. Representations, Warranties and Agreements to Survive Delivery. All
representations, warranties and agreements contained in this Underwriting Agreement or in
certificates of officers of the Company or its subsidiaries or of NAI submitted pursuant hereto
shall remain operative and in full force and effect, regardless of any investigation made by or on
behalf of any Underwriter or controlling person, or by or on behalf of the Company or NAI, and
shall survive delivery of and payment for the Shares.
9. Termination.
(a) Underwriting Agreement. The Representative may terminate this Underwriting
Agreement, by notice to the Company and NAI, at any time at or prior to the Closing Time, if on or
after the date hereof (i) there has occurred any material adverse change in the financial markets
in the United States or any new outbreak of hostilities or escalation thereof involving the United
States, in each case the effect of which is such as to make it, in the reasonable judgment of the
Representative, impracticable to market the Shares or to enforce contracts for the sale of the
Shares, or (ii) trading in any securities of the Company has been suspended by the Commission or
the New York Stock Exchange or the American Stock Exchange (other than pursuant to a request by the
Company with respect to an announcement by the Company of certain information not constituting a
material adverse change, since the date of the Underwriting Agreement, in the consolidated
financial condition or earnings of the Company and its subsidiaries, considered as one enterprise),
the effect of which is such as to make it, in the reasonable judgment of the Representative,
impracticable to market the Shares or to enforce contracts for the sale of the Shares, or
(iii) trading generally on the New York Stock Exchange or the American Stock Exchange has been
suspended or materially limited, or minimum or maximum prices for trading have been fixed, or
maximum ranges for prices have been required, by either of said exchanges or by such system or by
order of the Commission or any other governmental authority, or (iv) a banking moratorium has been
declared by either Federal or New York authorities.
(b) Liabilities. If this Underwriting Agreement is terminated pursuant to this
Section 9, such termination shall be without liability of any party to any other party except as
provided in Section 4 hereof, and provided further that Sections 6, 7, 8, this paragraph 9(b) and
Section 13 shall survive such termination and remain in full force and effect; provided,
however, if any condition specified in Section 5 hereof shall not have been fulfilled when
and as required to be fulfilled, this Agreement may be terminated by the Representative by notice
to the Company and NAI at any time at or prior to the Closing Time, and such termination shall be
22
without liability of any other party except that the provisions of Sections 6, 7, 8, this
paragraph 9(b) and Section 13 shall survive such termination and remain in full force and effect.
10. Default by One or More of the Underwriters. If one or more of the Underwriters
shall fail at the Closing Time to purchase the Shares which it or they are obligated to purchase
under this Underwriting Agreement (the “Defaulted Shares”), then the Representative shall have the
right, within 24 hours thereafter, to make arrangements for one or more of the non-defaulting
Underwriters, or any other underwriters, to purchase all, but not less than all, of the Defaulted
Shares in such amounts as may be agreed upon and upon the terms herein set forth; if, however, the
Representative shall not have completed such arrangements within such 24-hour period, then:
(a) if the number of Defaulted Shares does not exceed 10% of the number of Shares set forth on
Schedule 1 hereto, the non-defaulting Underwriters shall be obligated, severally and not jointly,
to purchase the full amount thereof in the proportions that their respective underwriting
obligations hereunder bear to the underwriting obligations of all non-defaulting Underwriters or in
such other proportions as the Representative may specify, or
(b) if the number of Defaulted Shares exceeds 10% of the number of Shares set forth on
Schedule 1 hereto, the non-defaulting Underwriters shall have the right to purchase all, but shall
not be under any obligation to purchase any, of the Shares.
No action taken pursuant to this Section 10 shall relieve any defaulting Underwriter from
liability in respect of its default.
In the event of any such default which does not result in a termination of this Underwriting
Agreement, either the Representative or the Company shall have the right to postpone the Closing
Time for a period not exceeding seven days in order to effect any required changes in the
Registration Statement or the Prospectus or in any other documents or arrangements.
11. Notices. All notices and other communications hereunder shall be in writing and
shall be deemed to have been duly given if mailed or transmitted by any standard form of
telecommunication. Notices to the Underwriters shall be directed to Citigroup Global Markets Inc.
General Counsel, facsimile (000) 000-0000, and confirmed to the General Counsel, Citigroup Global
Markets Inc., 000 Xxxxxxxxx Xxxxxx, Xxx Xxxx, XX 00000; notices to the Company shall be directed to
them at CBS Corporation, 00 Xxxx 00xx Xxxxxx, Xxx Xxxx, Xxx Xxxx 00000, attention of
General Counsel; and notices to NAI shall be directed to 000 Xxxxxxxxxx Xxxxxx, Xxxxxxx,
Xxxxxxxxxxxxx 00000, attention of Xxxxxxxx Xxxxxxxxx.
12. Parties. This Underwriting Agreement shall inure to the benefit of and be binding
upon the Company, NAI, the Representative and the other Underwriters and their respective
successors. Nothing expressed or mentioned in this Underwriting Agreement is intended or shall be
construed to give any person, firm or corporation, other than the Underwriters, the Company,
23
NAI and their respective successors and the controlling persons and officers and directors
referred to in Sections 6 and 7 and their heirs and legal representatives, any legal or equitable
right, remedy or claim under or in respect of this Underwriting Agreement or any provision herein
contained. This Underwriting Agreement and all conditions and provisions hereof are intended to be
for the sole and exclusive benefit of the parties hereto and their respective successors, and said
controlling persons and officers and directors and their heirs and legal representatives, and for
the benefit of no other person, firm or corporation. No purchaser of Shares from any Underwriter
shall be deemed to be a successor by reason merely of such purchase.
13. GOVERNING LAW. THIS UNDERWRITING AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO THE PRINCIPLES OF CONFLICTS OF
LAWS THEREOF.
14. Effect of Headings. The Article and Section headings herein and the Table of
Contents are for convenience only and shall not affect the construction hereof.
15. Counterparts. This Underwriting Agreement may be executed in two or more
counterparts, each of which shall be an original, with the same effect as if the signatures thereto
and hereto were on the same instrument.
24
If the foregoing is in accordance with your understanding of our agreement, please sign and
return to each of the Company and NAI a counterpart hereof, whereupon this Underwriting Agreement,
along with all counterparts, will become a binding agreement among each of the Underwriters, the
Company, and NAI in accordance with its terms.
Very truly yours, | ||||
CBS CORPORATION |
||||
By: | /s/ XXXXXX XXXXXXXXX | |||
Name: | Xxxxxx Xxxxxxxxx | |||
Title: | Executive Vice President and Chief Financial Officer | |||
NATIONAL AMUSEMENTS, INC. |
||||
By: | /s/ XXXXXXX XXXXXXX | |||
Name: | Xxxxxxx X. Xxxxxxx | |||
Title: | Vice President | |||
[Signature Page to Underwriting Agreement]
Accepted:
October 14, 2009
For itself and on behalf of the several
Underwriters listed in Schedule 1 hereto.
CITIGROUP GLOBAL MARKETS INC.
For itself and on behalf of the several
Underwriters listed in Schedule 1 hereto.
CITIGROUP GLOBAL MARKETS INC.
By:
|
/s/ XXXXXXX X. XXXX III
|
|||
Title: Managing Director |
[Signature Page to Underwriting Agreement]